CH372056A - Process for the preparation of 5-hydroxymethyl-2-oxazolidone ethers - Google Patents

Process for the preparation of 5-hydroxymethyl-2-oxazolidone ethers

Info

Publication number
CH372056A
CH372056A CH6599358A CH6599358A CH372056A CH 372056 A CH372056 A CH 372056A CH 6599358 A CH6599358 A CH 6599358A CH 6599358 A CH6599358 A CH 6599358A CH 372056 A CH372056 A CH 372056A
Authority
CH
Switzerland
Prior art keywords
ethers
oxazolidone
hydroxymethyl
preparation
condensing agent
Prior art date
Application number
CH6599358A
Other languages
French (fr)
Inventor
Pares Corominas Juan
Bulto Blajot Isidro
Original Assignee
Om Lab Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Om Lab Sa filed Critical Om Lab Sa
Priority to CH6599358A priority Critical patent/CH372056A/en
Publication of CH372056A publication Critical patent/CH372056A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D263/00Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/08Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D263/16Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D263/18Oxygen atoms
    • C07D263/20Oxygen atoms attached in position 2
    • C07D263/24Oxygen atoms attached in position 2 with hydrocarbon radicals, substituted by oxygen atoms, attached to other ring carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Description

  

  
 



  Procédé de préparation d'éthers de la 5-hydroxyméthyl-2-oxazolidone
 Le brevet   No    363345 décrit un procédé de préparation d'éthers de la   5-hydroxyméthyl-2-oxazoli-    done, par condensation d'un dérivé   oxyméthyi-      alcaaediol-1,2    avec de l'uréthane, à haute température et en présence d'un alcoolate métallique comme agent de condensation.



   On a trouvé maintenant que   l'on    peut, d'une part, substituer l'uréthanne par l'urée et, d'autre part, se passer d'un agent de condensation, bien que la présence de celui-ci augmente le rendement de la réaction. En outre, on a trouvé que parmi les agents de condensation utilisables,   l'amidure de    sodium en constitue un avantageux.



   Basée sur les constatations ci-dessus, la présente invention a pour objet un procédé de préparation d'éthers de la   5-hydroxyméthyl-2-oxazolidone    de   formule:   
EMI1.1     
 dans laquelle R est un radical   aromatique,    alicyclique ou aliphatique substitué ou non.



   Ce procédé est caractérisé en ce que   l'on    condense un éther de formule:    R-O-CH2-CHOH-CH20H    dans laquelle R a la mme signification que ci-dessus, avec de l'urée, à haute température.



   La condensation, bien que s'effectuant de   pré-    férence en l'absence   d'un    agent de condensation, peut tre exécutée en présence d'un tel agent, en particulier en présence d'amidure de sodium, ce qui en améliore le   rendement.    Les autres agents de   con-    densation tels que les alcoolates métalliques (spécialement alcalins) conviennent aussi.



   Le procédé de l'invention peut tre représenté comme suit:
EMI1.2     

 Le produit de la réaction se solidifie par refroi  pissement.    L'éther dérivé peut en tre extrait par dissolution à chaud dans. l'eau ou dans les alcools inférieurs et   recristallisation;    les volumes d'eau nécessaires sont toutefois quatre à six fois plus grands que ceux d'alcools. Certains des éthers obtenus ont une activité pharmacologique qui les rendent susceptibles d'utilisations thérapeutiques.



   Voici quelques exemples d'exécution du procédé de l'invention:
 Exemple I
 On prépare, comme agent de   condensation,    2,6 g (0,013 mole) d'isopropylate   d'aluminium    par le procédé décrit   plar    Roger Adams, Organic Reactions II, page 198. On y ajoute simultanément   18, 2 g    (0,1 mole)   d'o-toloxy-propane-diol-1, 2    et 12,012 g (0,2 mole) d'urée. On chauffe le mélange progressivement et dès qu'il atteint   170     C, on régularise la réaction en élevant peu à peu la température, de façon qu'après trois heures elle atteigne 2050 C.  



   Après refroidissement, on ajoute au produit de la réaction, qui se présente sous forme d'une pâte solidifiée, environ 100 g d'alcool à 960, chaud. On filtre la solution à chaud. Par refroidissement, elle abandonne un produit qui, recristallisé dans de l'eau, donne des cristaux incolores, point de fusion 1301310 C (corrigé).



   Exemple 2
 On mélange 19,8 g (0,1 mole) de (o-méthoxy  phénoxy)-propanediol-1,2    et   12,012 g    (0,2 mole) d'urée, puis on chauffe pour élever la température du mélange jusqu'à   1600 C.    On fait alors monter lentement la température de telle façon que, au cours d'un temps de réaction de quatre heures, elle atteigne 2050 C. On laisse refroidir jusqu'à la température ambiante. On dissout le produit de la réaction, solidifié, dans environ 100 cm3 d'alcool à 960, chaud. La solution est filtrée à chaud et, par refroidissement, on obtient un produit cristallin qui, recristallisé une fois dans de l'alcool éthylique, donne des cristaux aciculaires ou   lamiiaiformes,    incolores, de point de fusion   145-1460    C (corrigé).



   Exemple 3
 On mélange 19,8 g (0,1 mole) de (o-méthoxy  phénoxy)-propanediol-1,2,    12 g d'urée (0,2 mole) et   0, 50 g      (0,013    mole) d'amidure de sodium; on chauffe le tout pour élever la température du mélange jusqu'à 1600 C. On fait ensuite monter lentement la température de façon qu'au cours   d'un    temps de réaction de quatre heures, elle atteigne 2100 C. On laisse refroidir jusqu'à la température ambiante. On verse le produit de la réaction, solidifié, dans environ 450 cm3 d'eau chaude. La solution est filtrée, et, par refroidissement, on obtient avec un bon rendement un produit cristallin qui, recristallisé une fois dans de l'alcool éthylique, donne des cristaux aciculaires ou laminiformes, incolores, de point de fusion   145-1460    C (corrigé).
  



  
 



  Process for the preparation of 5-hydroxymethyl-2-oxazolidone ethers
 Patent No. 363345 describes a process for the preparation of ethers of 5-hydroxymethyl-2-oxazolidone, by condensation of a 1,2-oxymethyl-alcaaediol derivative with urethane, at high temperature and in the presence of a metal alcoholate as a condensing agent.



   It has now been found that it is possible, on the one hand, to substitute the urethane by urea and, on the other hand, to dispense with a condensing agent, although the presence of the latter increases the yield. of the reaction. In addition, it has been found that among the condensing agents which can be used, sodium amide constitutes an advantageous one.



   Based on the above findings, the present invention relates to a process for the preparation of 5-hydroxymethyl-2-oxazolidone ethers of formula:
EMI1.1
 in which R is an aromatic, alicyclic or aliphatic radical, substituted or not.



   This process is characterized in that an ether of formula is condensed: R-O-CH2-CHOH-CH20H in which R has the same meaning as above, with urea, at high temperature.



   The condensation, although preferably carried out in the absence of a condensing agent, can be carried out in the presence of such an agent, in particular in the presence of sodium amide, which improves its yield. . Other condensing agents such as metal alcoholates (especially alkaline) are also suitable.



   The process of the invention can be represented as follows:
EMI1.2

 The reaction product solidifies on cooling. The derived ether can be extracted therefrom by dissolving hot in. water or in lower alcohols and recrystallization; however, the volumes of water required are four to six times greater than those of alcohols. Some of the ethers obtained have pharmacological activity which makes them susceptible of therapeutic uses.



   Here are some examples of execution of the method of the invention:
 Example I
 As condensing agent, 2.6 g (0.013 mole) of aluminum isopropoxide is prepared by the method described by Roger Adams, Organic Reactions II, page 198. 18.2 g (0.1 mole) are simultaneously added thereto. ) o-toloxy-propanediol-1,2 and 12.012 g (0.2 mol) of urea. The mixture is gradually heated and as soon as it reaches 170 C, the reaction is regulated by gradually raising the temperature, so that after three hours it reaches 2050 C.



   After cooling, about 100 g of hot 960 alcohol is added to the reaction product, which is in the form of a solidified paste. The hot solution is filtered. On cooling, it gives up a product which, recrystallized from water, gives colorless crystals, melting point 1301310 C (corrected).



   Example 2
 19.8 g (0.1 mole) of (o-methoxy phenoxy) -propanediol-1,2 and 12.012 g (0.2 mole) of urea are mixed, then heated to raise the temperature of the mixture to 1600 C. The temperature is then increased slowly so that, during a reaction time of four hours, it reaches 2050 C. The temperature is allowed to cool to room temperature. The solidified reaction product is dissolved in about 100 cc of hot 960 alcohol. The solution is filtered while hot and, on cooling, a crystalline product is obtained which, recrystallized once from ethyl alcohol, gives acicular or lamiaiform, colorless crystals, melting point 145-1460 C (corrected).



   Example 3
 19.8 g (0.1 mole) of (o-methoxy phenoxy) -propanediol-1,2, 12 g of urea (0.2 mole) and 0.50 g (0.013 mole) of amide are mixed. sodium; the whole is heated to raise the temperature of the mixture to 1600 C. The temperature is then slowly raised so that during a reaction time of four hours, it reaches 2100 C. It is allowed to cool to Room temperature. The solidified reaction product is poured into about 450 cm3 of hot water. The solution is filtered, and, by cooling, a crystalline product is obtained with a good yield which, recrystallized once in ethyl alcohol, gives acicular or laminiform, colorless crystals, with a melting point of 145-1460 C (corrected ).
  

 

Claims (1)

REVENDICATION Procédé de préparation d'éthers de la 5-hydroxyméthyl-2-oxazolidone de formule: EMI2.1 dans laquelle R est un radical aromatique, alicyclique ou aliphatique substitué ou non, caractérisé en ce que l'on condense un éther de formule: R-O-CH2-CHOH-CH20H dans laquelle R a la mme signification que ci-dessus, avec de l'urée, à haute température. CLAIM Process for preparing 5-hydroxymethyl-2-oxazolidone ethers of the formula: EMI2.1 in which R is a substituted or unsubstituted aromatic, alicyclic or aliphatic radical, characterized in that an ether of formula: RO-CH2-CHOH-CH20H is condensed in which R has the same meaning as above, with l 'urea, at high temperature. SOUS-REVENDICATIONS 1. Procédé selon la revendication, caractérisé en ce que l'on effectue la condensation en présence d'un agent de condensation. SUB-CLAIMS 1. Method according to claim, characterized in that the condensation is carried out in the presence of a condensing agent. 2. Procédé selon la sous-revendication 1, carac térisé en ce que l'agent de condensation est l'amidure de sodium. 2. Method according to sub-claim 1, charac terized in that the condensing agent is sodium amide. 3. Procédé selon la sous-revendication 1, carac térisé en ce que l'agent de condensation est un alcoolate métallique. 3. Method according to sub-claim 1, charac terized in that the condensing agent is a metal alkoxide.
CH6599358A 1958-11-10 1958-11-10 Process for the preparation of 5-hydroxymethyl-2-oxazolidone ethers CH372056A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CH6599358A CH372056A (en) 1958-11-10 1958-11-10 Process for the preparation of 5-hydroxymethyl-2-oxazolidone ethers

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH6599358A CH372056A (en) 1958-11-10 1958-11-10 Process for the preparation of 5-hydroxymethyl-2-oxazolidone ethers

Publications (1)

Publication Number Publication Date
CH372056A true CH372056A (en) 1963-09-30

Family

ID=4526810

Family Applications (1)

Application Number Title Priority Date Filing Date
CH6599358A CH372056A (en) 1958-11-10 1958-11-10 Process for the preparation of 5-hydroxymethyl-2-oxazolidone ethers

Country Status (1)

Country Link
CH (1) CH372056A (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0425209A2 (en) * 1989-10-26 1991-05-02 Tanabe Seiyaku Co., Ltd. Naphthyloxazolidone derivatives

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0425209A2 (en) * 1989-10-26 1991-05-02 Tanabe Seiyaku Co., Ltd. Naphthyloxazolidone derivatives
EP0425209A3 (en) * 1989-10-26 1992-02-19 Tanabe Seiyaku Co., Ltd. Naphthyloxazolidone derivatives
US5182296A (en) * 1989-10-26 1993-01-26 Tanabe Seiyaky Co., Ltd. Naphthyloxazolidone derivatives
US5332754A (en) * 1989-10-26 1994-07-26 Tanabe Seiyaku Co., Ltd. Naphthyloxazolidone derivatives

Similar Documents

Publication Publication Date Title
CH375017A (en) Process for the preparation of novel imidazole derivatives
CH372056A (en) Process for the preparation of 5-hydroxymethyl-2-oxazolidone ethers
CH437340A (en) Process for the preparation of N- (2,3-dimethylphenyl) -anthranilic acid
BE583205A (en)
CH474465A (en) Process for the preparation of a dihydroxy-diketone
CH408953A (en) Process for the preparation of new substituted carbazates
CH354764A (en) Process for preparing a dicarbamate
BE633582A (en)
CH388975A (en) Process for the preparation of a reserpine derivative
EP0254611A1 (en) Derivatives of 8-phenylthiotetrahydroquinolines and their salts, their synthesis for use as medicaments and compositions containing them
CH382167A (en) Process for the preparation of 5-hydroxymethyl-2-oxazolidone ethers
CH363345A (en) Process for the preparation of 5-hydroxymethyl-2-oxazolidone ethers
EP0671375A1 (en) Preparation of 2,6-bis(trifluoromethyl) benzyl alcohol
CH396030A (en) Process for the preparation of N-isopropyl-N-benzyl-hydrazine and its salts
CH414667A (en) Process for preparing N- (2,3-dimethyl-phenyl) -anthranilic acid
CH363978A (en) Process for the preparation of α-estradiol
CH354766A (en) Process for the preparation of 2-methyl-2-phenyl-1,3-propane-dio dicarbamate
CH385210A (en) Process for preparing new quinolizines
CH333723A (en) Imidazolines manufacturing process
FR2599365A1 (en) PROCESS FOR THE PREPARATION OF DIPHENHYDRAMINE
CH268051A (en) Process for preparing 1-methyl-4-piperazine-N, N-diethyl-carboxamide.
CH352667A (en) Process for preparing 2-methyl-2-sec.butyl-1,3-propanediol dicarbamate
FR2575469A1 (en) N-imidazolylmethyl-diphenylazomethines, a process for preparing them and their therapeutic application
CH354765A (en) Process for preparing a dicarbamate
CH420107A (en) Process for the preparation of new substituted aralkylaminoalkylcyclohexane derivatives